VHFMoDRAD in numbers
14 Organisations
Details
VHFMoDRAD is a four-year European project (Collaborative Research Project) and is part of IMI’s EBOLA+ programme that was launched in 2014 to respond to the Ebola epidemic by accelerating all aspects of vaccine development and diagnostics. The project has started in January 2019 and is coordinated by Folkhälsomyndigheten (the Public Health Agency of Sweden, FoHM) represented by Professor Ali Mirazimi. The consortium brings together:
- 1) operational capacity with appropriate facilities,
- 2) experienced researchers,
- 3) authorities and entities,
- 4) clinical samples from endemic countries,
- 5) access to diagnostic hubs in epidemic areas,
- 6) a strong industrial partner, CEPHEID
- 7) SMEs and
- 8) an international network.
The project is supported by the EU’s research and innovation programme and CEPHEID Europe SAS through the Innovative Medicines Initiative (IMI). Two companies and consortium partners, Coris Bioconcept and RD Biotech, also provide financial support to the project.
The consortium
- RD-Biotech (RD-B), Jean-Luc Schlick
- CEPHEID EUROPE SAS, Dave Persing
- Institut national de la Santé et de la recherche médicale (INSERM), Hervé Raoul
- Aix-Marseille University (AMU), Rémi Charrel
- Inserm Transfert (IT), Sinéad Quigley
- RD-Biotech (RD-B), Jean-Luc Schlick
- CEPHEID EUROPE SAS, Dave Persing
- Institut national de la Santé et de la recherche médicale (INSERM), Hervé Raoul
- Aix-Marseille University (AMU), Rémi Charrel
- Inserm Transfert (IT), Sinéad Quigley
- Istituto Nazionale per le Malattie Infettive "L. Spallanzani" I.R.C.C.S (INMI), Antonino Di Caro
- Emergency (EMR), Gina Portella
- University of Copenhagen (UCPH), Ola Blixt
IPD Institut Pasteur de Dakar (IPD), Amadou Sall
- University of Stirling (UoS), Manfred Weidmann
- Department of Health, Public Health England (DH-PHE), Robert Watson
IPD Institut Pasteur de Dakar (IPD), Amadou Sall
6 EU, 1 Associated and 1 non EU Countries
VHFMoDRAD brings together cutting-edge complementary partners, including 1 large company, 2 small and medium enterprises, one technology transfer / management company, 9 research institution, from 6 European Member States (Sweden, UK, France, Belgium, Denmark, Italy), one NGO, one Associated country (Turkey) and an African country (Senegal), who will address the challenges of development and implementation of diagnostic tools in Africa, thus reinforcing the international and national response in the face of an outbreak.
Coordination
FoHM - Sweden
Folkhälsomyndigheten -
Public health agency of Sweden
Ali Mirazimi
Sweden
14 Partners
IT - France
INSERM Transfert
Sinéad Quigley
UoS- United Kingdom
University of Stirling
Manfred Weidmann
DH-PHE- United Kingdom
Department of Health,
Public Health England
Nadina Wand
CORIS- Belgium
Coris BioConcept SPRL
Pascal Mertens
INSERM - France
Institut national de la santé et de la recherche médicale
Hervé Raoul
UCPH- Denmark
University of Copenhagen
Ola Blixt
INMI- Italy
Istituto Nazionale per le Malattie Infettive "L. Spallanzani" I.R.C.C.S
Antonino Di Caro
IPD- Senegal
Institut Pasteur de Dakar
Amadou Sall
RD-B- France
RD-Biotech
Jean-Luc Schlick
CEPHEID- France
CEPHEID
Dave Persing
AMU- France
Université Aix Marseille
Rémi Charrel
EMR- Italy
Emergency
Gina Portella
